This winter has had absolutely no chill. The US has been experiencing intense, record-setting cold and persistent, widespread ...
Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced the completion of the ...
A study published in Nature looks at genetic determinants of persistent Epstein-Barr virus DNA and associations with chronic conditions. Prof Lawrence Young, Virologist and Emeritus Professor of ...
Fitness alone doesn’t guarantee heart health. Cardiologists explain lesser-known tests like hs-CRP, lipoprotein(a), calcium ...
US President Donald Trump was seen covering his left hand with a glove, fuelling intense discussion about his health as ...
Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, today ...
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...
(“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted oncology therapies and ...
Native American vs non-Native individuals showed a higher prevalence and incidence of statin-associated anti-HMHCR antibody IMNM.
Gensaic, Inc. (Gensaic), a metabolic health biotechnology company combining AI-guided protein evolution with multi-targeted siRNA to build next-generation precision medicines, today announced the ...
CalciMedica’s stock nosedived after the biotech abandoned a phase 2 study of its calcium release-activated calcium (CRAC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results